Exact Mass: 552.3215734

Exact Mass Matches: 552.3215734

Found 450 metabolites which its exact mass value is equals to given mass value 552.3215734, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Antioside

3beta-(6-deoxy-alpha-L-mannopyranosyloxy)-5,12beta,14-trihydroxy-5beta-card-20(22)-enolide

C29H44O10 (552.2934324)

Bipindogulomethyloside

4-{7,11,17-trihydroxy-2,15-dimethyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C29H44O10 (552.2934324)

Bipindogulomethyloside is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.

Canthiumine

C33H36N4O4 (552.2736416)

Pandamine

2-(Dimethylamino)-N-[11-hydroxy-3-isopropyl-5,8-dioxo-7-benzyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14(1),15-trien-4-yl]-3-methylpentanamide

C31H44N4O5 (552.3311534)

Panoside

Panogenin-3-o-alpha-L-rhamnopyranoside; Panoside

C29H44O10 (552.2934324)

Handelin

[(1R,2R,3R,3aR,4S,5S,6R,6aR,9S,9aR,9bR,10S,11R)-2,6-dihydroxy-2,6,9,11-tetramethyl-6-methylidene-2,7-dioxospiro[4,5,6a,7,9a,9b-hexahydro-3aH-azuleno[4,5-b]uran-3,15-8-oxatetracyclo[9.2.2.01,10.05,9]pentadec-12-ene]-4-yl] acetate

C32H40O8 (552.2723040000001)

Handelin is a sesterterpenoid. [(1R,2R,3R,3aR,4S,5S,6R,6aR,9S,9aR,9bR,10S,11R)-2,6-dihydroxy-2,6,9,11-tetramethyl-6-methylidene-2,7-dioxospiro[4,5,6a,7,9a,9b-hexahydro-3aH-azuleno[4,5-b]furan-3,15-8-oxatetracyclo[9.2.2.01,10.05,9]pentadec-12-ene]-4-yl] acetate is a natural product found in Tanacetum vulgare, Chrysanthemum lavandulifolium, and other organisms with data available. Handelin is a guaianolide dimer from Chrysanthemum boreale that has potent anti-inflammatory activity by down-regulating NF-κB signaling and pro-inflammatory cytokine production[1]. Handelin is a guaianolide dimer from Chrysanthemum boreale that has potent anti-inflammatory activity by down-regulating NF-κB signaling and pro-inflammatory cytokine production[1].

Triterpenoid

(4AS,6as,6BR,8ar,9R,10S,12ar,12BR,14BS)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulphooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C30H48O7S (552.3120578)

Triterpenoid is a byproduct from squalene 2,3-oxide decomposition. Squalene is a precursor to sterol biosynthesis. Terpenes are derived biosynthetically from units of isoprene, which has the molecular formula C5H8. The basic molecular formulas of terpenes are multiples of that, (C5H8)n where n is the number of linked isoprene units. This is called the isoprene rule or the C5 rule. The isoprene units may be linked together "head to tail" to form linear chains or they may can be arranged to form rings. One can consider the isoprene unit as one of natures preferred building blocks. [HMDB] Triterpenoid is a byproduct from squalene 2,3-oxide decomposition. Squalene is a precursor to sterol biosynthesis. Terpenes are derived biosynthetically from units of isoprene, which has the molecular formula C5H8. The basic molecular formulas of terpenes are multiples of that, (C5H8)n where n is the number of linked isoprene units. This is called the isoprene rule or the C5 rule. The isoprene units may be linked together "head to tail" to form linear chains or they may can be arranged to form rings. One can consider the isoprene unit as one of natures preferred building blocks.

Elastin

(2S)-1-[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-methylbutanoyl]-N-methylpyrrolidine-2-carboxamide

C27H48N6O6 (552.3635148)

lokundjoside

4-[(3S,5S,8R,9S,10R,11R,13R,14S,17R)-5,11,14-trihydroxy-10,13-dimethyl-3-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-5H-furan-2-one

C29H44O10 (552.2934324)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

Desglucocheirotoxol

4-[7,11-dihydroxy-2-(hydroxymethyl)-15-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]-2,5-dihydrofuran-2-one

C29H44O10 (552.2934324)

Convallatoxol is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA. Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.

Cyclopassifloic acid E

4,6,14-trihydroxy-7,12,16-trimethyl-15-[2,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O8 (552.3661992)

Cyclopassifloic acid E is found in fruits. Cyclopassifloic acid E is a constituent of Passiflora edulis (passion fruit) Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid E is found in fruits.

Lithocholate 3-O-glucuronide

(2S,3S,4S,5R,6R)-6-{[(1S,2S,5S,7R,10R,11S,14R,15R)-14-[(2R)-4-carboxybutan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H48O9 (552.3298158)

Analysis of sequential bile samples by thin-layer chromatography (TLC) demonstrated that lithocholic acid glucuronide was present in bile throughout the course of the experiments and that its secretion rate paralleled that of total isotope secretion. Initial confirmation of the identity of this metabolite was obtained by the recovery of labeled lithocholic acid after beta-glucuronidase hydrolysis of bile samples. Glucuronates; Lithocholic Acid. Analysis of sequential bile samples by thin-layer chromatography (TLC) demonstrated that lithocholic acid glucuronide was present in bile throughout the course of the experiments and that its secretion rate paralleled that of total isotope secretion. Initial confirmation of the identity of this metabolite was obtained by the recovery of labeled lithocholic acid after beta-glucuronidase hydrolysis of bile samples. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

Arbekacin

(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide

C22H44N6O10 (552.3118764)

Arbekacin is only found in individuals that have used or taken this drug. It is an semisynthetic aminoglycoside antibiotic. Often used for treatment of multi-resistant bacterial infection such as methicillin-resistant Staphylococcus aureus (MRSA). Amikacin is also nephrotoxic and ototoxic.Aminoglycosides, such as Arbekacin, inhibit protein synthesis in susceptible bacteria by irreversibly binding to bacterial 30S and 16S ribosomal subunits. Specifically Arbekacin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

Nonadecylresorcinol glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-hydroxy-5-nonadecylphenoxy)oxane-2-carboxylic acid

C31H52O8 (552.3661992)

Nonadecylresorcinol glucuronide is an alkylresorcinol metabolite. It is a potential plasma biomarker of whole grain intake (PMID: 25527657).

Elastin

1-{2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-4-methylpentylidene}amino)-3-methylpentylidene]amino}ethylidene)amino]-3-methylbutanoyl}-N-methylpyrrolidine-2-carboximidate

C27H48N6O6 (552.3635148)

Gilteritinib

6-Ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-2-pyrazinecarboxamide

C29H44N8O3 (552.3536194)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

D-Phenylalanyl-L-2-piperidinecarbonyl-N-(4-nitro phenyl)-L-argininamide

2-{[1-(2-amino-3-phenylpropanoyl)piperidin-2-yl]formamido}-5-[(diaminomethylidene)amino]-N-(4-nitrophenyl)pentanamide

C27H36N8O5 (552.2808526)

Lithocholic acid glucuronide

6-{[14-(4-carboxybutan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H48O9 (552.3298158)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

DG(8:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(8:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O8 (552.3661992)

DG(PGE2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(8:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(PGE2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(8:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O8 (552.3661992)

DG(PGD2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(8:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3661992)

DG(PGD2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C31H52O8 (552.3661992)

DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C31H52O8 (552.3661992)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C31H52O8 (552.3661992)

DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C31H52O8 (552.3661992)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Euhorbiasteroid

Benzeneacetic acid,(1aR,2'R,2E,4aR,6S,7S,7aR,8S,11aS)-4a,8-bis(acetyloxy)-1,1a,4,4a,5,6,7,7a,8,10,11,11a-dodecahydro-1,1,3,6-tetramethyl-4-oxospiro[9H-cyclopenta[a]cyclopropa[f]cycloundecene-9,2'-oxiran]-7-ylester

C32H40O8 (552.2723040000001)

Euphorbiasteroid is a natural product found in Macaranga tanarius and Euphorbia lathyris with data available.

EFL1 diterpene

[(3Z)-1,11-diacetyloxy-3,6,6,14-tetramethyl-2-oxospiro[oxirane-2,10-tricyclo[10.3.0.05,7]pentadec-3-ene]-13-yl] 2-phenylacetate

C32H40O8 (552.2723040000001)

Euphorbia

[(3Z)-1,11-diacetyloxy-3,6,6,14-tetramethyl-2-oxospiro[oxirane-2,10-tricyclo[10.3.0.05,7]pentadec-3-ene]-13-yl] 2-phenylacetate

C32H40O8 (552.2723040000001)

Bipindogulomethyloside

4-{7,11,17-trihydroxy-2,15-dimethyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C29H44O10 (552.2934324)

3-[(3R,5S,10R,13R,14S,17R)-5,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

3-[(3R,5S,10R,13R,14S,17R)-5,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

C29H44O10 (552.2934324)

Euphorbiasteroid

C32H40O8 (552.2723040000001)

C30H48O9

C30H48O9 (552.3298158)

Sarpedobiline

C33H36N4O4 (552.2736416)

5-Deooxy,6,7-deepoxy,6,7-didehydro-Huratoxin

C34H48O6 (552.3450708)

Cynanformoside B

C30H48O9 (552.3298158)

3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta)-14beta,13-[1]oxa[4]azapentano-18-nor-pregna-7,16-diene-3beta,11alpha-diol|Batrachotoxinin A-20-(2-ethyl-4-methyl-pyrrol-3-carboxylat) od. Homobatrachotoxin od. Isobatrachotoxin|homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-batrachotoxinin-A

3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta)-14beta,13-[1]oxa[4]azapentano-18-nor-pregna-7,16-diene-3beta,11alpha-diol|Batrachotoxinin A-20-(2-ethyl-4-methyl-pyrrol-3-carboxylat) od. Homobatrachotoxin od. Isobatrachotoxin|homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-batrachotoxinin-A

C32H44N2O6 (552.3199204)

Dihydroajugapitin

C29H44O10 (552.2934324)

sarmentogenin-3-O-beta-D-allopyranoside|sarmentogenin-3beta-O-(beta-D-alloside)|sarmentogenin-3beta-O-

C29H44O10 (552.2934324)

(19E,19E)-18,18-dideoxy-22,22-dinor-toxiferin-I|(19E,19E)-18,18-Didesoxy-22,22-dinor-toxiferin-I|Bisnordihydrotoxiferine|bisnordihydroxiferin|nordihydrotoxiferine

C38H40N4 (552.32528)

11-O-trans-Cinnamoyl-12-O-acetyl-17alphaH-marsdenin

C32H40O8 (552.2723040000001)

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside

C31H52O8 (552.3661992)

Glucocroglaucigenin

C29H44O10 (552.2934324)

Gitorin

C29H44O10 (552.2934324)

klysimplexin L

C30H48O9 (552.3298158)

(8E,12E,14E)-7-acetoxy-3,6,17,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide

C30H48O9 (552.3298158)

6-Benzoyl-(2alpha,3beta,5alpha,6beta,25S)-Spirostane-2,3,6-triol

C34H48O6 (552.3450708)

20S,23R,24R-23-chloro-20,24-epoxy-dammarane-3alpha,24,25-triol 3-acetate

C32H53ClO5 (552.3581318)

2-Deoxy-.alpha.-ecdysone, 22-O-benzoate

C34H48O6 (552.3450708)

(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide|(8E,12E,14E)-7-acetoxy-6,10,12,16,20-pentamethyl-3,6,16,21-tetrahydroxy-18,19-epoxytricosa-8,12,14-trien-11-olide|epi-(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19epoxytricosa-8,12,14-trien-11-olide

(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide|(8E,12E,14E)-7-acetoxy-6,10,12,16,20-pentamethyl-3,6,16,21-tetrahydroxy-18,19-epoxytricosa-8,12,14-trien-11-olide|epi-(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19epoxytricosa-8,12,14-trien-11-olide

C30H48O9 (552.3298158)

2-(beta-D-glucopyranosyloxy)-3,16-dihydroxy-4,4,9,14-tetramethyl-19-norpregn-5-en-20-one

C30H48O9 (552.3298158)

12beta-hydroxyfrugoside

C29H44O10 (552.2934324)

16beta-hydroxy-heteroclitalactone H|heteroclitalactone I

C32H40O8 (552.2723040000001)

gracigenine

C32H40O8 (552.2723040000001)

atroxigenine

C30H45ClO7 (552.285365)

tuscoron B

C30H48O9 (552.3298158)

trichilinin C

C33H44O7 (552.3086874)

Sanjoinine F

C31H44N4O5 (552.3311534)

propolone B

C33H44O7 (552.3086874)

schinchinenin A

C32H40O8 (552.2723040000001)

lineariifolianoid G

C32H40O8 (552.2723040000001)

lineariifolianoid H

C32H40O8 (552.2723040000001)

3-O-(beta-glucopyranosyl) acovenosigenin A

C29H44O10 (552.2934324)

C32H40O8

C32H40O8 (552.2723040000001)

gomphogenin 3-beta-D-glucopyranoside

C29H44O10 (552.2934324)

cochinchinoid J

C33H44O7 (552.3086874)

CHEMBL4101532

C32H40O8 (552.2723040000001)

angolensin A

C32H40O8 (552.2723040000001)

Sanjoinine G1

C31H44N4O5 (552.3311534)

C29H48N2O8

C29H48N2O8 (552.3410488)

klysimplexin H

C30H48O9 (552.3298158)

manumycin D

C31H40N2O7 (552.283537)

(1S,2R,3S,4R,5R,6S,8E,11S,12R,13S,14S)-3-acetoxy-2,12-dibutanoyloxycladiell-8-ene-4,11-diol

C30H48O9 (552.3298158)

hyperevoline

C32H40O8 (552.2723040000001)

C33H44O7

C33H44O7 (552.3086874)

Tetronolide

C32H40O8 (552.2723040000001)

Hyperbrasilol B

C32H40O8 (552.2723040000001)

longipedlactone N

C32H40O8 (552.2723040000001)

halolitoralin A

C27H48N6O6 (552.3635148)

SCHEMBL10630869

C29H48N2O8 (552.3410488)

C34H48O6

C34H48O6 (552.3450708)

Drevogenin I

C31H52O8 (552.3661992)

milnamide C

C31H44N4O5 (552.3311534)

3beta,27-dihydroxyolean-12-en-28-oic acid 3-sulfate ester

C30H48O7S (552.3120578)

11-(2-Methylbutanoyl),12-benzoyl-Tenacigenin B|11alpha-O-2-methylbutyryl-12beta-O-benzoyltenacigenin B

C33H44O7 (552.3086874)

propindilactone H

C29H44O10 (552.2934324)

Isohyperbrasilol B

C32H40O8 (552.2723040000001)

2-O-pentadecanoyl-2-hydroxy-8-methoxy-6,7-methylenedioxyisoflavone|aervin D

C32H40O8 (552.2723040000001)

3,4,5-trihydroxydrhydro-alpha-ionol-9-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside

C25H44O13 (552.2781774)

Ala Val His Val Lys

C25H44N8O6 (552.3383644)

2,3-DIACETOXY-7,8-EPOXY-24,29-DINOR-1,3,5-FRIEDELATRIENE-20-CARBOXYLIC ACID

C33H44O7 (552.3086874)

His Ile Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]hexanamido]-5-carbamimidamidopentanoic acid

C24H44N10O5 (552.3495974)

C29H44O10_Card-20(22)-enolide, 3-(beta-D-glucopyranosyloxy)-5,14-dihydroxy-, (3alpha,5beta,8xi,9xi)

NCGC00385999-01_C29H44O10_Card-20(22)-enolide, 3-(beta-D-glucopyranosyloxy)-5,14-dihydroxy-, (3alpha,5beta,8xi,9xi)-

C29H44O10 (552.2934324)

Euphorbiasteroid_major

C32H40O8 (552.2723040000001)

(2S,3S,4S,5R,6R)-6-(((3R,5R,8R,9S,10S,13R,14S,17R)-17-((R)-4-carboxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid

"(2S,3S,4S,5R,6R)-6-(((3R,5R,8R,9S,10S,13R,14S,17R)-17-((R)-4-carboxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid"

C30H48O9 (552.3298158)

Arbekacin

Arbekacinum, Habekacin, Arbekacin sulfate

C22H44N6O10 (552.3118764)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

Cys Phe Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C24H40N8O5S (552.284223)

Cys Phe Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C24H40N8O5S (552.284223)

Cys Lys Phe Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C24H40N8O5S (552.284223)

Cys Lys Arg Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C24H40N8O5S (552.284223)

Cys Arg Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]hexanoic acid

C24H40N8O5S (552.284223)

Cys Arg Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-phenylpropanoic acid

C24H40N8O5S (552.284223)

Asp Lys Lys Tyr

(3S)-3-amino-3-{[(1S)-5-amino-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}pentyl]carbamoyl}pentyl]carbamoyl}propanoic acid

C25H40N6O8 (552.290748)

Asp Lys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C25H40N6O8 (552.290748)

Asp Tyr Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanoic acid

C25H40N6O8 (552.290748)

Phe Cys Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]hexanamido]-5-carbamimidamidopentanoic acid

C24H40N8O5S (552.284223)

Phe Cys Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]hexanoic acid

C24H40N8O5S (552.284223)

Phe His His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C27H36N8O5 (552.2808526)

Phe His His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C27H36N8O5 (552.2808526)

Phe His Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

Phe His Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

Phe Ile His His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

Phe Lys Cys Arg

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C24H40N8O5S (552.284223)

Phe Lys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C26H44N6O5S (552.3093734)

Phe Lys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C26H44N6O5S (552.3093734)

Phe Lys Met Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C25H40N6O6S (552.27299)

Phe Lys Gln Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C25H40N6O6S (552.27299)

Phe Lys Arg Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C24H40N8O5S (552.284223)

Phe Leu His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

Phe Met Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]hexanamido]hexanoic acid

C26H44N6O5S (552.3093734)

Phe Met Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]hexanamido]-4-carbamoylbutanoic acid

C25H40N6O6S (552.27299)

Phe Met Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]hexanoic acid

C25H40N6O6S (552.27299)

Phe Gln Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C25H40N6O6S (552.27299)

Phe Gln Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C25H40N6O6S (552.27299)

Phe Arg Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]hexanoic acid

C24H40N8O5S (552.284223)

Phe Arg Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]hexanamido]-3-sulfanylpropanoic acid

C24H40N8O5S (552.284223)

His Phe His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C27H36N8O5 (552.2808526)

His Phe His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C27H36N8O5 (552.2808526)

His Phe Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

His Phe Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

His His Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C27H36N8O5 (552.2808526)

His His Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C27H36N8O5 (552.2808526)

His His Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C27H36N8O5 (552.2808526)

His His Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C27H36N8O5 (552.2808526)

His Ile Phe His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H36N8O5 (552.2808526)

His Ile His Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C27H36N8O5 (552.2808526)

His Ile Gln Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid